ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.

SLN Silence Therapeutics PLC

21,21
-1,74 (-7,58%)
11 Mai 2024 - Geschlossen
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Silence Therapeutics PLC SLN NASDAQ Depository Receipt
  Änderung Änderung % Aktuell Zeit
-1,74 -7,58% 21,21 02:00:00
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
22,84 21,23 23,09 21,21 22,95
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
08.5.202423:14EDGAR2Form DEL AM - Delaying amendment
30.4.202414:30BWSilence Therapeutics to Participate in Fireside Chat at H.C...
29.4.202414:30BWSilence Therapeutics Announces Retirement of Alistair Gray..
08.4.202417:48BWSilence Therapeutics Announces JAMA Publication of..
13.3.202412:05BWSilence Therapeutics Reports Full Year 2023 Financial..
13.3.202412:03IHMARKETNEWSMixed Futures Amidst Quiet Economic Schedule; Oil Prices..
13.3.202412:00BWSilence Therapeutics Announces Positive Topline 36-Week Data..
28.2.202414:00BWSilence Therapeutics to Report Fourth Quarter and Full Year..
23.2.202414:12EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
23.2.202414:00BWSilence Therapeutics Achieves $10 Million Milestone Payment..
14.2.202415:54EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14.2.202414:55EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
05.2.202414:00BWSilence Therapeutics Announces Oversubscribed $120 Million..
31.1.202413:00BWSilence Therapeutics to Participate in Fireside Chat at..
01.12.202313:00BWSilence Therapeutics Strengthens Executive Leadership Team..
14.11.202313:00BWSilence Therapeutics Highlights Recent Company Progress and..
08.11.202313:00BWSilence Therapeutics to Present at Jefferies London..
01.11.202312:00BWSilence Therapeutics Announces Positive Topline Results from..
26.9.202313:00BWSilence Therapeutics to Participate in Fireside Chat at..
06.9.202313:00BWSilence Therapeutics to Participate in September Investor..
29.8.202322:01EDGAR2Form 6-K/A - Report of foreign issuer [Rules 13a-16 and..
16.8.202313:00BWSilence Therapeutics Reports Second Quarter 2023 Results
01.8.202322:31EDGAR2Form S-8 - Securities to be offered to employees in employee..
11.7.202313:00EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
11.7.202313:00BWSilence Therapeutics Achieves $4 Million in Research..
31.5.202313:00BWSilence Therapeutics to Present at the Jefferies Healthcare..
16.5.202322:00BWSilence Therapeutics Reports First Quarter 2023 Results

Kürzlich von Ihnen besucht

Delayed Upgrade Clock